UniProt ID | IDH3A_HUMAN | |
---|---|---|
UniProt AC | P50213 | |
Protein Name | Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial | |
Gene Name | IDH3A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 366 | |
Subcellular Localization | Mitochondrion. | |
Protein Description | Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers.. | |
Protein Sequence | MAGPAWISKVSRLLGAFHNPKQVTRGFTGGVQTVTLIPGDGIGPEISAAVMKIFDAAKAPIQWEERNVTAIQGPGGKWMIPSEAKESMDKNKMGLKGPLKTPIAAGHPSMNLLLRKTFDLYANVRPCVSIEGYKTPYTDVNIVTIRENTEGEYSGIEHVIVDGVVQSIKLITEGASKRIAEFAFEYARNNHRSNVTAVHKANIMRMSDGLFLQKCREVAESCKDIKFNEMYLDTVCLNMVQDPSQFDVLVMPNLYGDILSDLCAGLIGGLGVTPSGNIGANGVAIFESVHGTAPDIAGKDMANPTALLLSAVMMLRHMGLFDHAARIEAACFATIKDGKSLTKDLGGNAKCSDFTEEICRRVKDLD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MAGPAWISKVSRLLG CCCHHHHHHHHHHHH | 19.12 | 29449344 | |
11 | Phosphorylation | PAWISKVSRLLGAFH HHHHHHHHHHHHHCC | 22.43 | 29449344 | |
22 (in isoform 2) | Ubiquitination | - | 42.97 | 21890473 | |
58 | Ubiquitination | MKIFDAAKAPIQWEE HHHHHHHCCCCCEEC | 57.31 | 21890473 | |
58 (in isoform 1) | Ubiquitination | - | 57.31 | 21890473 | |
58 | Acetylation | MKIFDAAKAPIQWEE HHHHHHHCCCCCEEC | 57.31 | 25953088 | |
58 | Malonylation | MKIFDAAKAPIQWEE HHHHHHHCCCCCEEC | 57.31 | 26320211 | |
66 | Methylation | APIQWEERNVTAIQG CCCCEECCCEEEEEC | 31.25 | 115480155 | |
69 | O-linked_Glycosylation | QWEERNVTAIQGPGG CEECCCEEEEECCCC | 22.92 | 29351928 | |
69 | Phosphorylation | QWEERNVTAIQGPGG CEECCCEEEEECCCC | 22.92 | - | |
77 (in isoform 1) | Ubiquitination | - | 39.23 | 21890473 | |
77 | Acetylation | AIQGPGGKWMIPSEA EEECCCCCEECCHHH | 39.23 | 23954790 | |
77 | Succinylation | AIQGPGGKWMIPSEA EEECCCCCEECCHHH | 39.23 | - | |
77 | Succinylation | AIQGPGGKWMIPSEA EEECCCCCEECCHHH | 39.23 | - | |
77 | Malonylation | AIQGPGGKWMIPSEA EEECCCCCEECCHHH | 39.23 | 26320211 | |
77 | Ubiquitination | AIQGPGGKWMIPSEA EEECCCCCEECCHHH | 39.23 | 21890473 | |
82 | Phosphorylation | GGKWMIPSEAKESMD CCCEECCHHHHHHHC | 38.98 | - | |
85 | Acetylation | WMIPSEAKESMDKNK EECCHHHHHHHCCCC | 46.39 | 26822725 | |
87 | Phosphorylation | IPSEAKESMDKNKMG CCHHHHHHHCCCCCC | 31.41 | - | |
90 | Acetylation | EAKESMDKNKMGLKG HHHHHHCCCCCCCCC | 50.23 | 12439119 | |
100 | Ubiquitination | MGLKGPLKTPIAAGH CCCCCCCCCCCCCCC | 56.22 | 21890473 | |
100 (in isoform 1) | Ubiquitination | - | 56.22 | 21890473 | |
100 | Acetylation | MGLKGPLKTPIAAGH CCCCCCCCCCCCCCC | 56.22 | 25953088 | |
100 | Malonylation | MGLKGPLKTPIAAGH CCCCCCCCCCCCCCC | 56.22 | 26320211 | |
101 | Phosphorylation | GLKGPLKTPIAAGHP CCCCCCCCCCCCCCC | 27.84 | - | |
109 | Phosphorylation | PIAAGHPSMNLLLRK CCCCCCCCHHHHHHH | 18.03 | 23312004 | |
116 | Ubiquitination | SMNLLLRKTFDLYAN CHHHHHHHHHHHHCC | 54.21 | - | |
117 | Phosphorylation | MNLLLRKTFDLYANV HHHHHHHHHHHHCCC | 18.89 | 28152594 | |
121 | Phosphorylation | LRKTFDLYANVRPCV HHHHHHHHCCCCCCE | 9.66 | 28152594 | |
129 | Phosphorylation | ANVRPCVSIEGYKTP CCCCCCEEECCCCCC | 22.95 | 28152594 | |
133 | Phosphorylation | PCVSIEGYKTPYTDV CCEEECCCCCCCCCE | 10.01 | 20068231 | |
135 | Phosphorylation | VSIEGYKTPYTDVNI EEECCCCCCCCCEEE | 17.03 | 28152594 | |
137 | Phosphorylation | IEGYKTPYTDVNIVT ECCCCCCCCCEEEEE | 22.32 | 28152594 | |
138 | Phosphorylation | EGYKTPYTDVNIVTI CCCCCCCCCEEEEEE | 34.37 | 28152594 | |
154 | Phosphorylation | ENTEGEYSGIEHVIV CCCCCCCCCCCEEEE | 29.06 | - | |
167 | Phosphorylation | IVDGVVQSIKLITEG EECCHHHHEEHHHCC | 15.30 | 24719451 | |
172 | Phosphorylation | VQSIKLITEGASKRI HHHEEHHHCCHHHHH | 38.51 | 20860994 | |
177 | Acetylation | LITEGASKRIAEFAF HHHCCHHHHHHHHHH | 47.49 | 25953088 | |
177 | Ubiquitination | LITEGASKRIAEFAF HHHCCHHHHHHHHHH | 47.49 | - | |
186 | Phosphorylation | IAEFAFEYARNNHRS HHHHHHHHHHHCCCC | 12.38 | 28152594 | |
193 | Phosphorylation | YARNNHRSNVTAVHK HHHHCCCCCCHHHHH | 28.27 | 21406692 | |
196 | Phosphorylation | NNHRSNVTAVHKANI HCCCCCCHHHHHHHH | 27.49 | 21406692 | |
200 | Acetylation | SNVTAVHKANIMRMS CCCHHHHHHHHHHHC | 36.21 | 25953088 | |
200 | Ubiquitination | SNVTAVHKANIMRMS CCCHHHHHHHHHHHC | 36.21 | - | |
206 | Sulfoxidation | HKANIMRMSDGLFLQ HHHHHHHHCCCCHHH | 2.07 | 21406390 | |
207 | Phosphorylation | KANIMRMSDGLFLQK HHHHHHHCCCCHHHH | 20.40 | 21712546 | |
214 | Acetylation | SDGLFLQKCREVAES CCCCHHHHHHHHHHH | 37.09 | 26822725 | |
214 | Ubiquitination | SDGLFLQKCREVAES CCCCHHHHHHHHHHH | 37.09 | - | |
223 | Acetylation | REVAESCKDIKFNEM HHHHHHCCCCCCCHH | 72.30 | 25953088 | |
223 | Ubiquitination | REVAESCKDIKFNEM HHHHHHCCCCCCCHH | 72.30 | - | |
331 | Glutathionylation | AARIEAACFATIKDG HHHHHHHEEEEECCC | 2.84 | 22555962 | |
334 | Phosphorylation | IEAACFATIKDGKSL HHHHEEEEECCCCCC | 14.33 | 28060719 | |
336 | Ubiquitination | AACFATIKDGKSLTK HHEEEEECCCCCCCC | 56.95 | - | |
336 | Acetylation | AACFATIKDGKSLTK HHEEEEECCCCCCCC | 56.95 | 25953088 | |
336 | Succinylation | AACFATIKDGKSLTK HHEEEEECCCCCCCC | 56.95 | 27452117 | |
343 | Succinylation | KDGKSLTKDLGGNAK CCCCCCCCCCCCCCC | 57.14 | 27452117 | |
343 | Ubiquitination | KDGKSLTKDLGGNAK CCCCCCCCCCCCCCC | 57.14 | 19608861 | |
343 | Succinylation | KDGKSLTKDLGGNAK CCCCCCCCCCCCCCC | 57.14 | - | |
343 | Acetylation | KDGKSLTKDLGGNAK CCCCCCCCCCCCCCC | 57.14 | 19608861 | |
350 | Succinylation | KDLGGNAKCSDFTEE CCCCCCCCCCHHHHH | 37.97 | - | |
350 | Ubiquitination | KDLGGNAKCSDFTEE CCCCCCCCCCHHHHH | 37.97 | - | |
350 | Malonylation | KDLGGNAKCSDFTEE CCCCCCCCCCHHHHH | 37.97 | 26320211 | |
350 | Acetylation | KDLGGNAKCSDFTEE CCCCCCCCCCHHHHH | 37.97 | 25953088 | |
350 | Succinylation | KDLGGNAKCSDFTEE CCCCCCCCCCHHHHH | 37.97 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IDH3A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IDH3A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IDH3A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
S10AG_HUMAN | S100A16 | physical | 22939629 | |
SUCB1_HUMAN | SUCLA2 | physical | 22939629 | |
MBNL1_HUMAN | MBNL1 | physical | 21988832 | |
RAB4A_HUMAN | RAB4A | physical | 21988832 | |
IDH3B_HUMAN | IDH3B | physical | 26186194 | |
RDH13_HUMAN | RDH13 | physical | 26186194 | |
IDH3G_HUMAN | IDH3G | physical | 26186194 | |
MRP1_HUMAN | ABCC1 | physical | 26344197 | |
MRP3_HUMAN | ABCC3 | physical | 26344197 | |
ACON_HUMAN | ACO2 | physical | 26344197 | |
ACTN4_HUMAN | ACTN4 | physical | 26344197 | |
AT2B1_HUMAN | ATP2B1 | physical | 26344197 | |
TCPQ_HUMAN | CCT8 | physical | 26344197 | |
HDHD1_HUMAN | HDHD1 | physical | 26344197 | |
IDHC_HUMAN | IDH1 | physical | 26344197 | |
IPO9_HUMAN | IPO9 | physical | 26344197 | |
PSMD2_HUMAN | PSMD2 | physical | 26344197 | |
SUCB1_HUMAN | SUCLA2 | physical | 26344197 | |
UBE2N_HUMAN | UBE2N | physical | 26344197 | |
QCR2_HUMAN | UQCRC2 | physical | 26344197 | |
IDH3G_HUMAN | IDH3G | physical | 28514442 | |
IDH3B_HUMAN | IDH3B | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-343, AND MASS SPECTROMETRY. |